Articles Tagged With:
-
Salmonella Gastroenteritis — The Risk of a Rapid, Accurate Diagnosis
Availability of molecular testing panel results that were positive for Salmonella in children led to increased hospital admissions, increased subsequent microbiologic testing, and increased antibiotic use — all without benefit to patients.
-
Statin Use with Daptomycin: Do We Finally Have a Definitive Answer?
A meta-analysis on published literature and a disproportionality analysis using Food and Drug Administration data found that statin use was associated with the occurrence of daptomycin-induced musculoskeletal adverse events. In most cases, statin use should be discontinued while patients are on daptomycin.
-
Another Emerging Infection, as Cholera Makes a Call
Clinicians should be prepared to identify and treat cholera in returning travelers using designated infection control measures to prevent hospital transmission, the Centers for Disease Control and Prevention reported.
-
EPINet: Needlesticks Spike 13% from 2020 to 2021
The largest noticeable needlestick increases from 2020 to 2021 were among injections with disposable syringes, especially with insulin needles and those used for vaccinations, says Amber Mitchell, DrPH, director of the International Safety Center, noted for its longstanding EPINet surveillance system for needlesticks, sharps injuries, and mucosal blood exposures.
-
Vaccine Second Shot, Boosters Kick in Protective Effect
A study of healthcare and other frontline workers with COVID-19 showed that a history of two or three messenger ribonucleic acid vaccine doses lessened the severity of illness significantly.
-
Device Nurses Can Prevent CLABSIs
A recent study estimated the average central line-associated bloodstream infection (CLABSI) costs $48,108, while increasing patient mortality by 12% to 25%. These costs and patient consequences may ensue if the central line is not routinely observed and maintained. Thus, one hospital system justified hiring two epidemiology nurses in 2018 after years of trying to claw back CLABSI rates by various interventions.
-
Viral Swarm: ‘Tripledemic’ Pushes Healthcare Facilities to the Brink
Respiratory infections are causing hospitalizations and deaths nationally in an unprecedented trifecta of influenza, respiratory syncytial virus, and COVID-19.
-
A Review of Insulin Transition
Diabetes mellitus is a collection of chronic metabolic diseases that occur either as the result of insulin deficiency or insulin resistance. One of the primary goals in diabetes treatment includes lowering blood glucose levels sufficiently to prevent microvascular and macrovascular complications. The type of insulin prescribed depends on multiple factors, and insulins frequently are interchanged. Before choosing or transitioning to an appropriate insulin, consider all social determinants and individualize the treatment regimen as “one size does not fit all.”
-
Several Groups ‘Deeply Concerned’ About AHRQ’s ED Diagnostics Report
Frontline providers take issue with references cited and data interpretation, among other problems.
-
SAMHSA Seeks Opioid Treatment Program Expansion
Under a proposed rule change, the agency wants to tear down more barriers to addiction treatment.